Journal article
Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity
DK Cole, AM Bulek, G Dolton, AJ Schauenberg, B Szomolay, W Rittase, A Trimby, P Jothikumar, A Fuller, A Skowera, J Rossjohn, C Zhu, JJ Miles, M Peakman, L Wooldridge, PJ Rizkallah, AK Sewell
Journal of Clinical Investigation | AMER SOC CLINICAL INVESTIGATION INC | Published : 2016
DOI: 10.1172/JCI85679
Open access
Abstract
The cross-reactivity of T cells with pathogen- and self-derived peptides has been implicated as a pathway involved in the development of autoimmunity. However, the mechanisms that allow the clonal T cell antigen receptor (TCR) to functionally engage multiple peptide-major histocompatibility complexes (pMHC) are unclear. Here, we studied multiligand discrimination by a human, preproinsulin reactive, MHC class-I-restricted CD8+ T cell clone (1E6) that can recognize over 1 million different peptides. We generated high-resolution structures of the 1E6 TCR bound to 7 altered peptide ligands, including a pathogenderived peptide that was an order of magnitude more potent than the natural self-pepti..
View full abstractGrants
Awarded by Research Councils UK
Funding Acknowledgements
Primary support for this work was provided by the UK Biotechnology and Biological Sciences Research Council (grant BB/H001085/1). A.K. Sewell is a Wellcome Trust Investigator. D.K. Cole is a Wellcome Trust Research Career Development Fellow (WT095767). P.J. Rizkallah was supported by a RCUK Fellowship. Support for 2D affinity studies was provided by US NIH (grant R01AI124680-01 and R01GM096187 to C. Zhu). We thank the MX staff on beamlines IO2, IO3, IO4-1, and I24, as well as CD staff on beamline B23 at DLS for providing facilities and support.